Cargando…
Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
Introduction––Serum pepsinogen tests for gastric cancer screening have been debated for decades. We assessed the performance of two pepsinogen assays with or without gastrin-17 for the detection of different precancerous lesions alone or as a composite endpoint in a Latvian cohort. Methods––Within t...
Autores principales: | Robles, Claudia, Rudzite, Dace, Polaka, Inese, Sjomina, Olga, Tzivian, Lilian, Kikuste, Ilze, Tolmanis, Ivars, Vanags, Aigars, Isajevs, Sergejs, Liepniece-Karele, Inta, Razuka-Ebela, Danute, Parshutin, Sergej, Murillo, Raul, Herrero, Rolando, Young Park, Jin, Leja, Marcis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325279/ https://www.ncbi.nlm.nih.gov/pubmed/35885649 http://dx.doi.org/10.3390/diagnostics12071746 |
Ejemplares similares
-
Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study
por: Leja, Marcis, et al.
Publicado: (2017) -
The Diagnostic Value of Anti-Parietal Cell and Intrinsic Factor Antibodies, Pepsinogens, and Gastrin-17 in Corpus-Restricted Atrophic Gastritis
por: Kriķe, Petra, et al.
Publicado: (2022) -
Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
por: Razuka-Ebela, Danute, et al.
Publicado: (2022) -
Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?
por: Skrebinska, Sabine, et al.
Publicado: (2022) -
Taxonomy-based data representation for data mining: an example of the magnitude of risk associated with H. pylori infection
por: Polaka, Inese, et al.
Publicado: (2021)